Cochlear (Australia) Performance
| COH Stock | 305.86 0.42 0.14% |
Cochlear has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.32, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cochlear's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cochlear is expected to be smaller as well. Cochlear right now shows a risk of 1.24%. Please confirm Cochlear mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to decide if Cochlear will be following its price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cochlear are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical indicators, Cochlear is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Forward Dividend Yield 0.0137 | Payout Ratio 0.6906 | Forward Dividend Rate 4.2 | Ex Dividend Date 2024-09-17 |
1 | Cochlear Limited Issues New Employee Incentive Securities - TipRanks | 09/25/2024 |
2 | Envoy Medicals Groundbreaking Cochlear Implant Shows Promise in Clinical Study COCH Stock News - StockTitan | 11/12/2024 |
3 | Cochlear Limited Signals Confidence with Buy-Back Program - TipRanks | 11/21/2024 |
| Begin Period Cash Flow | 555.5 M |
Cochlear |
Cochlear Relative Risk vs. Return Landscape
If you would invest 29,820 in Cochlear on August 30, 2024 and sell it today you would earn a total of 766.00 from holding Cochlear or generate 2.57% return on investment over 90 days. Cochlear is generating 0.0465% of daily returns assuming 1.2385% volatility of returns over the 90 days investment horizon. Simply put, 11% of all stocks have less volatile historical return distribution than Cochlear, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Cochlear Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cochlear's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cochlear, and traders can use it to determine the average amount a Cochlear's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0376
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | COH |
Estimated Market Risk
| 1.24 actual daily | 11 89% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Cochlear is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cochlear by adding it to a well-diversified portfolio.
Cochlear Fundamentals Growth
Cochlear Stock prices reflect investors' perceptions of the future prospects and financial health of Cochlear, and Cochlear fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cochlear Stock performance.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 19.75 B | ||||
| Shares Outstanding | 65.46 M | ||||
| Price To Book | 10.88 X | ||||
| Price To Sales | 9.01 X | ||||
| Revenue | 2.26 B | ||||
| Gross Profit | 1.45 B | ||||
| EBITDA | 578.9 M | ||||
| Net Income | 356.8 M | ||||
| Cash And Equivalents | 555.5 M | ||||
| Total Debt | 243.7 M | ||||
| Book Value Per Share | 28.10 X | ||||
| Cash Flow From Operations | 388.8 M | ||||
| Earnings Per Share | 5.44 X | ||||
| Total Asset | 2.75 B | ||||
| Retained Earnings | 667.9 M | ||||
About Cochlear Performance
Assessing Cochlear's fundamental ratios provides investors with valuable insights into Cochlear's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Cochlear is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Cochlear is entity of Australia. It is traded as Stock on AU exchange.Things to note about Cochlear performance evaluation
Checking the ongoing alerts about Cochlear for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cochlear help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cochlear is unlikely to experience financial distress in the next 2 years | |
| Latest headline from news.google.com: Cochlear Limited Signals Confidence with Buy-Back Program - TipRanks |
- Analyzing Cochlear's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cochlear's stock is overvalued or undervalued compared to its peers.
- Examining Cochlear's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cochlear's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cochlear's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cochlear's stock. These opinions can provide insight into Cochlear's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cochlear Stock Analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.